47 minutes ago
Hims & Hers Health, Inc. (HIMS) Stock: Peptides+ Launch Expands Healthcare Services
TLDR HIMS stock falls 2.93% to $17.04 despite the launch of its Peptides+ service. Peptides+ debuts with five treatments guided by licensed medical providers. Hims & Hers adds cellular health services to its growing telehealth platform. Care+ offers twice-yearly lab tests and ongoing support from medical teams. Hims & Hers plans to add BPC-157 and [...]
The post Hims & Hers Health, Inc. (HIMS) Stock: Peptides+ Launch Expands Healthcare Services appeared first on Blockonomi.
Source: Blockonomi →Related News
- 30 minutes ago
Verizon Communications Inc. (VZ) Stock: Rise as Bosch Expands IoT Partnership
- 1 hour ago
TD SYNNEX Corporation (SNX) Stock: Targets AI Growth With Microsoft Copilot Expa...
- 1 hour ago
Pony AI Inc. (PONY) Stock: Q3 Revenue Surges 75% as Net Loss Hits $136M
- 2 hours ago
Comcast Corporation (CMCSA) Stock: Fastly Partnership Targets GTA VI Gaming Boom
- 2 hours ago
Microsoft (MSFT) Stock: Rebounds as Intel Foundry Partnership Boosts Azure AI Ex...
